Wang H, Li L, Zhou G, Wang L, Wu Z
Can Respir J. 2025; 2025:7139235.
PMID: 39957991
PMC: 11824382.
DOI: 10.1155/carj/7139235.
Khassafi F, Chelladurai P, Valasarajan C, Nayakanti S, Martineau S, Sommer N
Nat Cardiovasc Res. 2024; 2(10):917-936.
PMID: 39196250
PMC: 11358157.
DOI: 10.1038/s44161-023-00338-3.
Brownstein A, Mura M, Ruffenach G, Channick R, Saggar R, Kim A
Am J Physiol Lung Cell Mol Physiol. 2024; 327(4):L520-L534.
PMID: 39137526
PMC: 11482468.
DOI: 10.1152/ajplung.00166.2024.
Deng J, Wei R, Zhang W, Shi C, Yang R, Jin M
Sci Rep. 2024; 14(1):12716.
PMID: 38830933
PMC: 11148111.
DOI: 10.1038/s41598-024-62900-8.
Alinaghi S, Mohseni M, Fattahi Z, Beheshtian M, Ghodratpour F, Ashrafi F
Arch Iran Med. 2024; 27(2):79-88.
PMID: 38619031
PMC: 11017261.
DOI: 10.34172/aim.2024.13.
Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension.
Zuo Y, Li B, Gao M, Xiong R, He R, Li N
Respir Res. 2024; 25(1):147.
PMID: 38555425
PMC: 10981837.
DOI: 10.1186/s12931-024-02772-8.
Gender-specific genetic and epigenetic signatures in cardiovascular disease.
Bridges J, Ramirez-Guerrero J, Rosa-Garrido M
Front Cardiovasc Med. 2024; 11:1355980.
PMID: 38529333
PMC: 10962446.
DOI: 10.3389/fcvm.2024.1355980.
Sex chromosome mechanisms in cardiac development and disease.
Conlon F, Arnold A
Nat Cardiovasc Res. 2023; 2(4):340-350.
PMID: 37808586
PMC: 10558115.
DOI: 10.1038/s44161-023-00256-4.
The Impact of Abnormal Lipid Metabolism on the Occurrence Risk of Idiopathic Pulmonary Arterial Hypertension.
Wei Y, Zhao H, Kalionis B, Huai X, Hu X, Wu W
Int J Mol Sci. 2023; 24(18).
PMID: 37762581
PMC: 10532109.
DOI: 10.3390/ijms241814280.
The impact of chromosomal sex on cardiometabolic health and disease.
Wiese C, Avetisyan R, Reue K
Trends Endocrinol Metab. 2023; 34(10):652-665.
PMID: 37598068
PMC: 11090013.
DOI: 10.1016/j.tem.2023.07.003.
Sex-biased TGFβ signalling in pulmonary arterial hypertension.
Wits M, Becher C, de Man F, Sanchez-Duffhues G, Goumans M
Cardiovasc Res. 2023; 119(13):2262-2277.
PMID: 37595264
PMC: 10597641.
DOI: 10.1093/cvr/cvad129.
Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension.
Ye Y, Xu Q, Wuren T
Front Immunol. 2023; 14:1162556.
PMID: 37215139
PMC: 10196112.
DOI: 10.3389/fimmu.2023.1162556.
Sexual dimorphism in chronic respiratory diseases.
Reddy K, Oliver B
Cell Biosci. 2023; 13(1):47.
PMID: 36882807
PMC: 9993607.
DOI: 10.1186/s13578-023-00998-5.
Pulmonary Arterial Hypertension: Emerging Principles of Precision Medicine across Basic Science to Clinical Practice.
Kelly N, Chan S
Rev Cardiovasc Med. 2023; 23(11).
PMID: 36875282
PMC: 9980296.
DOI: 10.31083/j.rcm2311378.
Sex-limited chromosomes and non-reproductive traits.
Cirulis A, Hansson B, Abbott J
BMC Biol. 2022; 20(1):156.
PMID: 35794589
PMC: 9261002.
DOI: 10.1186/s12915-022-01357-5.
Illuminating the Mechanisms Underlying Sex Differences in Cardiovascular Disease.
Reue K, Wiese C
Circ Res. 2022; 130(12):1747-1762.
PMID: 35679362
PMC: 9202078.
DOI: 10.1161/CIRCRESAHA.122.320259.
A dUTY to Protect: Addressing "Y" We See Sex Differences in Pulmonary Hypertension.
Rao R, Chan S
Am J Respir Crit Care Med. 2022; 206(2):137-139.
PMID: 35549630
PMC: 9887418.
DOI: 10.1164/rccm.202204-0653ED.
Y-Chromosome Gene, , Protects Against Pulmonary Hypertension by Reducing Proinflammatory Chemokines.
Cunningham C, Li M, Ruffenach G, Doshi M, Aryan L, Hong J
Am J Respir Crit Care Med. 2022; 206(2):186-196.
PMID: 35504005
PMC: 9887415.
DOI: 10.1164/rccm.202110-2309OC.
A narrative review of research advances in hypoxic pulmonary hypertension.
Chai T, Qiu C, Xian Z, Lu Y, Zeng Y, Li J
Ann Transl Med. 2022; 10(4):230.
PMID: 35280399
PMC: 8908157.
DOI: 10.21037/atm-22-259.
The Impact of Sex Chromosomes in the Sexual Dimorphism of Pulmonary Arterial Hypertension.
Predescu D, Mokhlesi B, Predescu S
Am J Pathol. 2022; 192(4):582-594.
PMID: 35114193
PMC: 8978209.
DOI: 10.1016/j.ajpath.2022.01.005.
